Zacks recently named three potentially promising healthcare stocks despite changes from healthcare reform and the medical device excise tax.
The report names Inogen, a company focused on advanced respiratory products for the homecare setting; Echo Therapeutics, a company focused on a wireless continuous glucose monitoring system for the critical care setting; and Bacterin, a biologics company including products in the orthopedics space among the stocks that "look promising."
All three companies have a long-term expected growth rate:
• 22 percent for Inogen
• 20 percent for Bacterin
• 40 percent for Echo Therapeutics
The report also names Stryker and Zimmer among the leading companies to benefit in the orthopedics market, with the growing number of baby boomers expected to seek care over the next two decades.